Skip to Content

Methylphenidate Extended-Release Oral Suspension and Chewable Tablets

Last Updated: January 6, 2018
Status: Current

Methylphenidate Extended-Release Oral Suspension and Chewable Tablets

Products Affected - Description
  • Extended-Release Chewable Tablets
    QuilliChews chewable tablet, Pfizer
    20 mg, vial, 100 count (NDC 24478-0120-01)
    30 mg, vial, 100 count (NDC 24478-0130-01)


Extended-Release Suspension

Quillivant XR oral powder for suspension, Pfizer
5 mg/mL, 60 mL bottle (NDC 24478-0190-10)
5 mg/mL, 120 mL bottle (NDC 24478-0200-20)
5 mg/mL, 150 mL bottle (NDC 24478-0205-25)
5 mg/mL, 180 mL bottle (NDC 24478-0210-30)
Reason for the Shortage
  • Pfizer has Quillivant XR and Quillichews on shortage due to manufacturing delays.

Available Products
  • Extended-Release Chewable Tablets
    QuilliChews chewable tablet, Pfizer
    40 mg, vial, 100 count (NDC 24478-0140-01)

Estimated Resupply Dates

    • Pfizer has Quillivant XR 5 mg/mL extended-release oral suspension in 60 mL, 120 mL, 150 mL, and 180 mL bottles on back order and the company cannot estimate a release date.
    • Pfizer has QuilliChews 20 mg and 30 mg extended-release chewable tablets in 100 count on back order and the company cannot estimate a release date.

Updated

January 6, 2018, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.
Hide